HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men.

Abstract
Nine of 10 consecutively evaluated men with DSM-III-R nonparaphilic sexual addictions or paraphilias noted improvement in sexual behaviors and depressive symptomatology while treated with fluoxetine, imipramine, or lithium. Depression was measured by means of the Inventory to Diagnose Depression. Sexual behavior was assessed in two dimensions, nonconventional interest and intensified desire, as measured by total sexual outlet. The author conceptualizes these behaviors as sexual dysregulation disorders associated with a primary mood disorder.
AuthorsM P Kafka
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 52 Issue 2 Pg. 60-5 (Feb 1991) ISSN: 0160-6689 [Print] United States
PMID1993637 (Publication Type: Journal Article)
Chemical References
  • Antidepressive Agents
  • Fluoxetine
  • Lithium
  • Imipramine
  • Trazodone
Topics
  • Adult
  • Antidepressive Agents (therapeutic use)
  • Depressive Disorder (complications, drug therapy, psychology)
  • Fluoxetine (therapeutic use)
  • Humans
  • Imipramine (therapeutic use)
  • Lithium (therapeutic use)
  • Male
  • Masturbation (drug therapy)
  • Middle Aged
  • Paraphilic Disorders (complications, drug therapy, psychology)
  • Psychiatric Status Rating Scales
  • Sexual Behavior (drug effects)
  • Sexual Dysfunctions, Psychological (complications, drug therapy, psychology)
  • Trazodone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: